Abstract Allopregnanolone, a 3α,5α-progesterone metabolite, acts as a potent allosteric modulator of the γ-aminobutyric acid type A receptor. In the present review, the synthesis of this neuroactive steroid occurring in the nervous system is discussed with respect to physiological and...
Maria Uloko, MD, discusses symptoms, causes, and treatments for post-finasteride syndrome (PFS) and post-SSRI sexual dysfunction (PSSD) in men. She explains the controversy behind the PFS diagnosis and discusses the attention it has gathered in urology, citing the NIH’s inclusion of PFS in its...
Nadine Hornig, PhD is Principal Investigator at the Institute for Human Genetics at University Medical Center Schleswig-Holstein and Kiel University. Dr. Hornig conducts research in the areas of molecular biology, genetics, epigenetics, and endocrinology and was recently published in the...
Post-Finasteride Syndrome is the current term for a rare syndrome of devastating physical, neurological, and sexual side effects that persist and progress after stopping finasteride. The condition occurs primarily in younger men who have taken the drug to treat hair loss. There is currently no...
US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know? (2023) Haidar Al Saffar, Jennifer Xu, Jonathan S. O’Brien, Brian D. Kelly, Declan G. Murphy, Nathan Lawrentschuk Abstract Finasteride competitively inhibits 5a-reductase (5-AR)...
5-alpha reductase inhibitors use in prostatic disease and beyond (2023) Bodie Chislett, David Chen, Marlon L. Perera, Eric Chung, Damien Bolton, Liang G. Qu Abstract 5-alpha reductase inhibitors (5-ARIs) are commonly used and widely available, with benefits observed from their effect on...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.